Solventum prices 8.8M share secondary offering

* Solventum (NYSE:SOLV [https://seekingalpha.com/symbol/SOLV]) priced [https://seekingalpha.com/pr/20200461-solventum-announces-pricing-of-secondary-offering-of-common-stock] a previously announced secondary offering of 8.8M shares of its common stock, which is expected to result in gross proceeds of approximately $648M to 3M Company.
* All of the shares of common stock are being sold by the selling shareholder, and Solventum will not receive any of the proceeds.
* The offering is expected to close on or about Aug. 15, 2025.

MORE ON SOLVENTUM CORPORATION

* Solventum Corporation 2025 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4811008-solventum-corporation-2025-q2-results-earnings-call-presentation]
* Solventum Corporation (SOLV) Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4811007-solventum-corporation-solv-q2-2025-earnings-call-transcript]
* Solventum: Appealing Again [https://seekingalpha.com/article/4803005-solventum-appealing-again]
* Solventum raises 2025 EPS guidance to $5.80-$5.95 with sales growth outlook up to 3% as transformation gains momentum [https://seekingalpha.com/news/4482436-solventum-raises-2025-eps-guidance-to-5_80-5_95-with-sales-growth-outlook-up-to-3-percent-as]
* Steris, Solventum upgraded, RxSight downgraded in Morgan Stanley's MedTech review [https://seekingalpha.com/news/4467601-steris-solventum-stocks-upgraded-morgan-stanley]